New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
10:40 EDTMDR, TRIP, CTRP, HZNP, OLEDOptions with decreasing implied volatility: OLED HZNP TRIP CTRP MDR
News For OLED;HZNP;TRIP;CTRP;MDR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
10:36 EDTTRIPExpedia results seen as positive indicator for Priceline earnings beat
Subscribe for More Information
08:24 EDTTRIPTripAdvisor volatility elevated into Q3 and outlook
TripAdvisor November weekly call option implied volatility is at 71, December is at 42, January is at 36; compares to its 26-week average of 45 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on November 4.
October 28, 2014
10:08 EDTCTRPCtrip.com threatened by Alibaba partnership with Shiji, Forbes says
Subscribe for More Information
October 27, 2014
08:02 EDTTRIPTripAdvisor should be bought before Q3 results, says Pacific Crest
Subscribe for More Information
October 23, 2014
07:42 EDTHZNPPOZEN receives three patents from USPTO
POZEN (POZN) announced that it has received three patents from the United States Patent and Trademark Office, entitled “Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs” that cover the U.S. approved product VIMOVO. All three patents are expected to expire in 2022. Horizon Pharma (HZNP), which holds the U.S. NDA for VIMOVO, and POZEN plan to list U.S. patents 8,858,996 and 8,852,636 in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.
October 21, 2014
10:00 EDTTRIP, CTRPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:08 EDTCTRPCtrip.com initiated with a Buy at Citigroup
Subscribe for More Information
October 20, 2014
16:42 EDTMDRMcDermott subsidiary awarded contract by PETRONAS subsidiary
Subscribe for More Information
16:24 EDTCTRPPriceline raises stake in Ctrip.com to 7.9% from 6.88%
16:05 EDTTRIPTripAdvisor initiated with an Outperform at Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use